Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption - Judit Demeter; Julia Weisinger; Zsolt Nagy (Mediterranean Journal of Hematology and Infectious Diseases)